MENU
AVIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Atea Pharmaceuticals (AVIR) Ownership - Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
55
Web
https://www.ateapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
346.48M
P/E Ratio
-2.08
Total Cash
219.47M
Projected Growth
N/A
Total Debt
424K
Revenue
N/A
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash/Share
2.74
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Atea Pharmaceuticals? AVIR symbol Ownership - Tickeron.com